Dimension Therapeutics, Inc. (Nasdaq: DMTX)

A class action complaint in the United States District Court for the District of Massachusetts on behalf of holders of Dimension Therapeutics, Inc. (“Dimension”) (DMTX) common stock in connection with the proposed acquisition of Dimension by Ultragenyx Pharmaceutical Inc. and its affiliate (“Ultragenyx”) announced on October 3, 2017 (the “Complaint”). The Complaint, which alleges violations of the Securities Exchange Act of 1934 against Dimension, its Board of Directors (the “Board”), and Ultragenyx.

On October 2, 2017, Dimension entered into an agreement and plan of merger (the “Merger Agreement”) with Ultragenyx. Pursuant to the Merger Agreement, shareholders of Dimension will receive $6.00 in cash for each share of Dimension common stock they own (the “Proposed Transaction”).

Among other things, the Complaint alleges that, in an attempt to secure shareholder support for the Proposed Transaction, defendants issued materially incomplete disclosures in a Solicitation Statement (the “Solicitation Statement”) filed with the United States Securities and Exchange Commission. The Complaint alleges that the Solicitation Statement omits material information necessary to enable shareholders to make an informed decision as to how to tender their shares in the tender offer, including material information with respect to Dimension’s financial projections and potential conflicts of interest. The Complaint seeks injunctive and equitable relief and damages on behalf of holders of Dimension common stock.

If you are a current shareholder and would like to discuss your options of exercising your rights as a shareholder, which include ensuring that the company is getting the highest possible price for the company, and that the board of directors will act in the best interest of the shareholders, please contact us.

Please submit the following information so we can determine if you qualify for the suit. If you don't know all the specific details, partial information is also acceptable.

Personal Information
Phone #:
E-mail Address:
Stock Information
Do you currently own the stock? Yes   No
Purchase Date:
Quantity Purchased:
Purchase Price Per Share:

Please Note: Neither the submission to nor the receipt of information by The Law Offices of Marc S. Henzel or one of its attorneys through this website constitutes an agreement by the firm to represent the individual and does not create an attorney-client relationship.